Robert Lenk
Directeur/Membre du Conseil chez PLUS THERAPEUTICS, INC.
Fortune : 48 829 $ au 30/04/2024
Postes actifs de Robert Lenk
Sociétés | Poste | Début | Fin |
---|---|---|---|
PLUS THERAPEUTICS, INC. | Directeur/Membre du Conseil | 01/03/2020 | - |
Independent Dir/Board Member | 01/03/2020 | - | |
Houston Partners
Houston Partners Investment ManagersFinance Houston Partners identifies regional and national investment opportunities and develops into nationally and internationally recognized public companies. It invests in early-stage and expanding companies, and focuses on the environment, technology, and health sciences. The company was founded in 1986 and is headquartered in Houston, TX. | Corporate Officer/Principal | - | - |
Lenk Pharmaceuticals, LLC | President | 01/01/2016 | - |
POP Biotechnologies, Inc.
POP Biotechnologies, Inc. BiotechnologyHealth Technology POP Biotechnologies, Inc. is a biotechnology company. The private company is based in Buffalo, NY. The company was founded in 2015 by Jonathan Lovell, Jonathan Smyth, Kevin Carter. | Directeur/Membre du Conseil | - | - |
Historique de carrière de Robert Lenk
Anciens postes connus de Robert Lenk
Sociétés | Poste | Début | Fin |
---|---|---|---|
MediVector, Inc. | Directeur Technique/Scientifique/R&D | - | 01/01/2016 |
LUNA INNOVATIONS INCORPORATED | Corporate Officer/Principal | 01/01/2004 | 15/04/2010 |
Therapeutics 2000, Inc. | Directeur Général | 01/01/1995 | 01/09/2003 |
President | 01/01/1995 | 01/09/2003 | |
Argus Pharmaceuticals, Inc. | Directeur Technique/Scientifique/R&D | 01/01/1989 | - |
Fondateur | 01/01/1989 | - | |
The Liposome Co., Inc.
The Liposome Co., Inc. Pharmaceuticals: MajorHealth Technology The Liposome Co., Inc. is a biopharmaceutical company engaged in the discovery, development, manufacturing and marketing of proprietary lipid- and liposome-based pharmaceuticals, primarily for the treatment of cancer and other related life-threatening illnesses. | Fondateur | 01/01/1981 | - |
░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ | ░░░░░░░░░░ | - |
Formation de Robert Lenk
Massachusetts Institute of Technology | Doctorate Degree |
Statistiques
Internationale
Etats-Unis | 12 |
Opérationnelle
President | 3 |
Corporate Officer/Principal | 2 |
Director/Board Member | 2 |
Sectorielle
Health Technology | 5 |
Finance | 3 |
Electronic Technology | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 2 |
---|---|
LUNA INNOVATIONS INCORPORATED | Electronic Technology |
PLUS THERAPEUTICS, INC. | Health Technology |
Entreprise privées | 8 |
---|---|
The Liposome Co., Inc.
The Liposome Co., Inc. Pharmaceuticals: MajorHealth Technology The Liposome Co., Inc. is a biopharmaceutical company engaged in the discovery, development, manufacturing and marketing of proprietary lipid- and liposome-based pharmaceuticals, primarily for the treatment of cancer and other related life-threatening illnesses. | Health Technology |
Argus Pharmaceuticals, Inc. | Health Technology |
Houston Partners
Houston Partners Investment ManagersFinance Houston Partners identifies regional and national investment opportunities and develops into nationally and internationally recognized public companies. It invests in early-stage and expanding companies, and focuses on the environment, technology, and health sciences. The company was founded in 1986 and is headquartered in Houston, TX. | Finance |
MediVector, Inc. | |
OncoVector, Inc. | |
Therapeutics 2000, Inc. | |
Lenk Pharmaceuticals, LLC | |
POP Biotechnologies, Inc.
POP Biotechnologies, Inc. BiotechnologyHealth Technology POP Biotechnologies, Inc. is a biotechnology company. The private company is based in Buffalo, NY. The company was founded in 2015 by Jonathan Lovell, Jonathan Smyth, Kevin Carter. | Health Technology |
- Bourse
- Insiders
- Robert Lenk
- Expérience